(Q30938118)

27 June 2017

title

Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants (English)

1 reference

27 June 2017

Cynthia F Shuman

1

1 reference

27 June 2017

Per Olof Markgren

2

1 reference

27 June 2017

Markku Hämäläinen

3

1 reference

27 June 2017

U Helena Danielson

4

1 reference

27 June 2017

Cynthia F. Shuman

1

0 references

Per-Olof Markgren

2

0 references

U.Helena Danielson

4

0 references

publication date

1 May 2003

1 reference

27 June 2017

May 2003

0 references

published in

Antiviral Research

1 reference

27 June 2017

volume

58

1 reference

27 June 2017

issue

3

1 reference

27 June 2017

page(s)

235-242

1 reference

Resistance profiles of cyclic and linear inhibitors of HIV-1 protease

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Resistance to human immunodeficiency virus type 1 protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Investigation of an allosteric site of HIV-1 proteinase involved in inhibition by Cu2+

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Antigen-antibody binding and mass transport by convection and diffusion to a surface: a two-dimensional computer model of binding and dissociation kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Affinity analysis of non-steady-state data obtained under mass transport limited conditions using BIAcore technology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase n

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Screening of compounds interacting with HIV-1 proteinase using optical biosensor technology.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Kinetic analysis of the interaction between HIV-1 protease and inhibitors using optical biosensor technology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Relationships between structure and interaction kinetics for HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Structural and kinetic analyses of the protease from an amprenavir-resistant human immunodeficiency virus type 1 mutant rendered resistant to saquinavir and resensitized to amprenavir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Improving biosensor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Advances in surface plasmon resonance biosensor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

1 reference

7 January 2021

Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Targeting the HIV-protease in AIDS therapy: a current clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900002-0

7 January 2021

10.1016/S0166-3542(03)00002-0

Identifiers

DOI

0 references

1 reference